The Effects of Wearing Lower Body Compression Garments During a Cycling Performance Test

2013 ◽  
Vol 8 (3) ◽  
pp. 300-306 ◽  
Author(s):  
Matthew W. Driller ◽  
Shona L. Halson

Purpose:Compression garments have been commonly used in a medical setting as a method to promote blood flow. Increases in blood flow during exercise may aid in the delivery of oxygen to the exercising muscles and, subsequently, enhance performance. The aim of the current study was to investigate the effect of wearing lower body compression garments during a cycling test.Methods:Twelve highly trained cyclists (mean ± SD age 30 ± 6 y, mass 75.6 ± 5.8 kg, VO2peak 66.6 ± 3.4 mL · kg−1 · min−1) performed two 30-min cycling bouts on a cycle ergometer in a randomized, crossover design. During exercise, either full-length lower body compression garments (COMP) or above-knee cycling shorts (CON) were worn. Cycling bouts involved 15 min at a fixed workload (70% of VO2max power) followed by a 15-min time trial. Heart rate (HR) and blood lactate (BL) were measured during the fixed-intensity component of the cycling bout to determine the physiological effect of the garments. Calf girth (CG), thigh girth (TG) and perceived soreness (PS) were measured preexercise and postexercise.Results:COMP produced a trivial effect on mean power output (ES = .14) compared with CON (mean ± 95% CI 1.3 ±1.0). COMP was also associated with a lower HR during the fixed-workload section of the test (−2.6% ± 2.3%, ES = −.38). There were no differences between groups for BL, CG, TG, and PS.Conclusion:Wearing compression garments during cycling may result in trivial performance improvements of ~1% and may enhance oxygen delivery to the exercising muscles.

2012 ◽  
Vol 22 (3) ◽  
pp. 175-183 ◽  
Author(s):  
Andrew E. Kilding ◽  
Claire Overton ◽  
Jonathan Gleave

Purpose:To determine the effects of ingesting caffeine (CAFF) and sodium bicarbonate (SB), taken individually and simultaneously, on 3-km cycling time-trial (TT) performance.Method:Ten well-trained cyclists, age 24.2 ± 5.4 yr, participated in this acute-treatment, double-blind, crossover study that involved four 3-km cycling TTs performed on separate days. Before each TT, participants ingested either 3 mg/kg body mass (BM) of CAFF, 0.3 g · kg−1 · BM−1 of SB, a combination of the two (CAFF+SB), or a placebo (PLAC). They completed each 3-km TT on a laboratory-based cycle ergometer, during which physiological, perceptual, and performance measurements were determined. For statistical analysis, the minimal worthwhile difference was considered ~1% based on previous research.Results:Pretrial pH and HCO3 were higher in SB and CAFF+SB than in the CAFF and PLAC trials. Differences across treatments for perceived exertion and gastric discomfort were mostly unclear. Compared with PLAC, mean power output during the 3-km TT was higher in CAFF, SB, and CAFF+SB trials (2.4%, 2.6%, 2.7% respectively), resulting in faster performance times (–0.9, –1.2, –1.2% respectively). Effect sizes for all trials were small (0.21–0.24).Conclusions:When ingested individually, both CAFF and SB enhance high-intensity cycling TT performance in trained cyclists. However, the ergogenic effect of these 2 popular supplements was not additive, bringing into question the efficacy of coingesting the 2 supplements before short-duration high-intensity exercise. In this study there were no negative effects of combining CAFF and SB, 2 relatively inexpensive and safe supplements.


2008 ◽  
Vol 3 (4) ◽  
pp. 424-438 ◽  
Author(s):  
Aaron T. Scanlan ◽  
Benjamin J. Dascombe ◽  
Peter R.J. Reaburn ◽  
Mark Osborne

Purpose:The present investigation examined the physiological and performance effects of lower-body compression garments (LBCG) during a one-hour cycling time-trial in well-trained cyclists.Methods:Twelve well-trained male cyclists ([mean ± SD] age: 20.5 ± 3.6 years; height: 177.5 ± 4.9 cm; body mass: 70.5 ± 7.5 kg; VO2max: 55.2 ± 6.8 mL·kg−1·min−1) volunteered for the study. Each subject completed two randomly ordered stepwise incremental tests and two randomly ordered one-hour time trials (1HTT) wearing either full-length SportSkins Classic LBCG or underwear briefs (control). Blood lactate concentration ([BLa−]), heart rate (HR), oxygen consumption (VO2) and muscle oxygenation (mOxy) were recorded throughout each test. Indicators of cycling endurance performance were anaerobic threshold (AnT) and VO2max values from the incremental test, and mean power (W), peak power (W), and total work (kJ) from the 1HTT Magnitude-based inferences were used to determine if LBCG demonstrated any performance and/or physiological benefits.Results:A likely practically significant increase (86%:12%:2%; η2 = 0.6) in power output at AnT was observed in the LBCG condition (CONT: 245.9 ± 55.7 W; LBCG: 259.8 ± 44.6 W). Further, a possible practically significant improvement (78%:19%:3%; η2 = 0.6) was reported in muscle oxygenation economy (W·%mOxy−1) across the 1HTT (mOxy: CONT: 52.2 ± 12.2%; LBCG: 57.3 ± 8.2%).Conclusions:The present results demonstrated limited physiological benefits and no performance enhancement through wearing LBCG during a cycling time trial.


2014 ◽  
Vol 9 (2) ◽  
pp. 340-345 ◽  
Author(s):  
Matthew W. Driller ◽  
Christos K. Argus ◽  
Jason C. Bartram ◽  
Jacinta Bonaventura ◽  
David T. Martin ◽  
...  

Purpose:To determine the intraday and interday reliability of a 2 × 4-min performance test on a cycle ergometer (Wattbike) separated by 30 min of passive recovery (2 × 4MMP).Methods:Twelve highly trained cyclists (mean ± SD; age = 20 ± 2 y, predicted VO2max = 59.0 ± 3.6 mL · kg−1 · min−1) completed six 2 × 4MMP cycling tests on a Wattbike ergometer separated by 7 d. Mean power was measured to determine intraday (test 1 [T1] to test 2 [T2]) and interday reliability (weeks 1–6) over the repeated trials.Results:The mean intraday reliabilities of the 2 × 4MMP test, as expressed by the typical error of measurement (TEM, W) and coefficient of variation (CV, %) over the 6 wk, were 10.0 W (95% confidence limits [CL] 8.2–11.8), and 2.6% (95%CL 2.1–3.1), respectively. The mean interday reliability TEM and CV for T1 over the 6 wk were 10.4 W (95%CL 8.7–13.3) and 2.7% (95%CL 2.3–3.5), respectively, and 11.7 W (95%CL 9.8–15.1) and 3.0% (95%CL 2.5–3.9) for T2.Conclusion:The testing protocol performed on a Wattbike cycle ergometer in the current study is reproducible in highly trained cyclists. The high intraday and interday reliability make it a reliable method for monitoring cycling performance and for investigating factors that affect performance in cycling events.


2015 ◽  
Vol 25 (3) ◽  
pp. 285-292 ◽  
Author(s):  
Michael L. Newell ◽  
Angus M. Hunter ◽  
Claire Lawrence ◽  
Kevin D. Tipton ◽  
Stuart D. R. Galloway

In an investigator-blind, randomized cross-over design, male cyclists (mean± SD) age 34.0 (± 10.2) years, body mass 74.6 (±7.9) kg, stature 178.3 (±8.0) cm, peak power output (PPO) 393 (±36) W, and VO2max 62 (±9) ml·kg−1min−1 training for more than 6 hr/wk for more than 3y (n = 20) completed four experimental trials. Each trial consisted of a 2-hr constant load ride at 95% of lactate threshold (185 ± 25W) then a work-matched time trial task (~30min at 70% of PPO). Three commercially available carbohydrate (CHO) beverages, plus a control (water), were administered during the 2-hr ride providing 0, 20, 39, or 64g·hr−1 of CHO at a fluid intake rate of 1L·hr−1. Performance was assessed by time to complete the time trial task, mean power output sustained, and pacing strategy used. Mean task completion time (min:sec ± SD) for 39g·hr−1 (34:19.5 ± 03:07.1, p = .006) and 64g·hr−1 (34:11.3 ± 03:08.5 p = .004) of CHO were significantly faster than control (37:01.9 ± 05:35.0). The mean percentage improvement from control was −6.1% (95% CI: −11.3 to −1.0) and −6.5% (95% CI: −11.7 to −1.4) in the 39 and 64g·hr−1 trials respectively. The 20g·hr−1 (35:17.6 ± 04:16.3) treatment did not reach statistical significance compared with control (p = .126) despite a mean improvement of −3.7% (95% CI −8.8−1.5%). No further differences between CHO trials were reported. No interaction between CHO dose and pacing strategy occurred. 39 and 64g·hr−1 of CHO were similarly effective at improving endurance cycling performance compared with a 0g·hr−1 control in our trained cyclists.


2019 ◽  
Vol 44 (2) ◽  
pp. 208-215 ◽  
Author(s):  
Paul T. Morgan ◽  
Anni Vanhatalo ◽  
Joanna L. Bowtell ◽  
Andrew M. Jones ◽  
Stephen J. Bailey

Recent research suggests that acute consumption of pharmacological analgesics can improve exercise performance, but the ergogenic potential of ibuprofen (IBP) administration is poorly understood. This study tested the hypothesis that IBP administration would enhance maximal exercise performance. In one study, 13 physically active males completed 60 × 3-s maximal voluntary contractions (MVCs) of the knee extensors interspersed with 2-s passive recovery periods, on 2 occasions, with the critical torque (CT) estimated as the mean torque over the last 12 contractions (part A). In another study, 16 active males completed two 3-min all-out tests against a fixed resistance on an electronically braked cycle ergometer, with the critical power estimated from the mean power output over the final 30 s of the test (part B). All tests were completed 60 min after ingestion of maltodextrin (placebo, PL) or 400 mg of IBP. Peripheral nerve stimulation was administered at regular intervals and electromyography was measured throughout. For part A, mean torque (IBP: 60% ± 13% of pre-exercise MVC; PL: 58% ± 14% of pre-exercise MVC) and CT (IBP: 41% ± 16% of pre-exercise MVC; PL: 40% ± 15% of pre-exercise MVC) were not different between conditions (P > 0.05). For part B, end-test power output (IBP: 292 ± 28 W; PL: 288 ± 31 W) and work done (IBP: 65.9 ± 5.9 kJ; PL: 65.4 ± 6.4 kJ) during the 3-min all-out cycling tests were not different between conditions (all P > 0.05). For both studies, neuromuscular fatigue declined at a similar rate in both conditions (P > 0.05). In conclusion, acute ingestion of 400 mg of IBP does not improve single-leg or maximal cycling performance in healthy humans.


2019 ◽  
Vol 44 (4) ◽  
pp. 434-442 ◽  
Author(s):  
Paul T. Morgan ◽  
Anni Vanhatalo ◽  
Joanna L. Bowtell ◽  
Andrew M. Jones ◽  
Stephen J. Bailey

Acute acetaminophen (ACT) ingestion has been shown to enhance cycling time-trial performance. The purpose of this study was to assess whether ACT ingestion enhances muscle activation and critical power (CP) during maximal cycling exercise. Sixteen active male participants completed two 3-min all-out tests against a fixed resistance on an electronically braked cycle ergometer 60 min after ingestion of 1 g of ACT or placebo (maltodextrin, PL). CP was estimated as the mean power output over the final 30 s of the test and W′ (the curvature constant of the power–duration relationship) was estimated as the work done above CP. The femoral nerve was stimulated every 30 s to measure membrane excitability (M-wave) and surface electromyography (EMGRMS) was recorded continuously to infer muscle activation. Compared with PL, ACT ingestion increased CP (ACT: 297 ± 32 W vs. PL: 288 ± 31 W, P < 0.001) and total work done (ACT: 66.4 ± 6.5 kJ vs. PL: 65.4 ± 6.4 kJ, P = 0.03) without impacting W′ (ACT: 13.1 ± 2.9 kJ vs. PL: 13.6 ± 2.4 kJ, P = 0.19) or the M-wave amplitude (P = 0.66) during the 3-min all-out cycling test. Normalised EMGRMS amplitude declined throughout the 3-min protocol in both PL and ACT conditions; however, the decline in EMGRMS amplitude was attenuated in the ACT condition, such that the EMGRMS amplitude was greater in ACT compared with PL over the last 60 s of the test (P = 0.04). These findings indicate that acute ACT ingestion might increase performance and CP during maximal cycling exercise by enhancing muscle activation.


2017 ◽  
Vol 56 (1) ◽  
pp. 119-126 ◽  
Author(s):  
Leonie Harvey ◽  
Matthew Bousson ◽  
Chris McLellan ◽  
Dale Lovell

AbstractThe 30 second Wingate Anaerobic Test (WAnT) is the gold standard measure of anaerobic performance. The present investigation aimed to determine if a previous WAnT using one body region significantly affected a subsequent WAnT using a different body region. Twelve male university students (n = 12, 23 ± 2 years, 84 ± 16.1 kg, 178.5 ± 7.4 cm) volunteered to complete two repeated WAnT protocols (either lower body WAnT followed by an upper body WAnT or vice versa) on two separate testing occasions. The upper body WAnT was conducted on a modified electromagnetically braked cycle ergometer using a flywheel braking force corresponding to 5% bodyweight. The lower body WAnT was conducted on an electronically braked cycle ergometer using a flywheel braking force corresponding to 7.5% bodyweight. Participants had a 1 minute rest period for transition between WAnTs. Data are reported as mean ± standard deviation. No significant differences were identified in power indices for the lower body between 30 s WAnTs. When the upper body WAnT was performed 2nd, absolute peak power (p < 0.01), mean power (p < 0.001) and relative mean power (p < 0.001) were significantly lower compared to when the upper body WAnT was performed 1st. The value of maximum revolutions per minute was significantly lower (p < 0.001) when the upper body WAnT was performed after the lower body WAnT, compared to when it was performed 1st (193.3 ± 11.4 1st vs 179.8 ± 14.4 2nd). Previous upper body sprint exercise does not significantly affect lower body sprint exercise; however, previous lower body sprint exercise severely compromises subsequent upper body sprint performance.


2018 ◽  
Vol 13 (7) ◽  
pp. 882-890 ◽  
Author(s):  
James R. Broatch ◽  
David J. Bishop ◽  
Shona Halson

Purpose: Evidence supporting the use of lower-limb compression garments during repeated-sprint exercise (RSE) with short rest periods, where performance will rely heavily on aerobic metabolism, is lacking. Methods: A total of 20 recreationally active participants completed 2 cycling RSE sessions, with and without lower-limb compression tights. The RSE session consisted of 4 sets of 10 × 6-s maximal sprints on a wind-braked cycle ergometer, interspaced by 24 s of recovery between bouts and 2 min of recovery between sets. Muscle oxygen consumption () of, and blood flow (mBF) to, the right vastus lateralis muscle was measured during exercise using near-infrared spectroscopy and venous/arterial occlusions of the right lower limb. Cycling performance, oxygen consumption (), heart rate, and capillary blood samples (lactate, pH, bicarbonate, and base excess) were also measured/taken throughout the session. Results: Compared with control, peak power (40.7 [19.9] W; mean ± 95% confidence intervals) and mBF (0.101 [0.061] mL·min−1·100 g−1) were higher, and heart rate (2  [1] beats/min) was lower, when participants wore compression (P < .05). , , blood lactate, and heart rate increased as a result of exercise (P < .05), with no differences between conditions. Similarly, blood pH, bicarbonate, and base excess decreased as a result of exercise (P < .05), with no difference between conditions. Conclusions: Wearing lower-limb compression tights during RSE with short intervals of rest improved cycling performance, vastus lateralis mBF, and heart rate. These results provide novel data to support the notion that lower-limb compression garments aid RSE performance, which may be related to local and/or central blood flow.


2010 ◽  
Vol 20 (2) ◽  
pp. 122-131 ◽  
Author(s):  
Darren Triplett ◽  
J. Andrew Doyle ◽  
Jeffrey C. Rupp ◽  
Dan Benardot

A number of recent research studies have demonstrated that providing glucose and fructose together in a beverage consumed during exercise results in significantly higher oxidation rates of exogenous carbohydrate (CHO) than consuming glucose alone. However, there is insufficient evidence to determine whether the increased exogenous CHO oxidation improves endurance performance. The purpose of this study was to determine whether consuming a beverage containing glucose and fructose (GF) would result in improved cycling performance compared with an isocaloric glucose-only beverage (G). Nine male competitive cyclists (32.6 ± 5.8 years, peak oxygen uptake 61.5 ± 7.9 ml · kg-1 · min-1) completed a familiarization trial and then 2 simulated 100-km cycling time trials on an electronically braked Lode cycle ergometer separated by 5–7 d. During the randomly ordered experimental trials, participants received 36 g of CHO of either G or GF in 250 ml of water every 15 min. All 9 participants completed the 100-km time trial significantly faster when they received the GF beverage than with G (204.0 ± 23.7 vs. 220.6 ± 36.6 min; p = .023). There was no difference at any time point between trials for blood glucose or for blood lactate. Total CHO oxidation increased significantly from rest during exercise but was not statistically significant between the GF and G trials, although there was a trend for CHO oxidation to be higher with GF in the latter stages of the time trial. Consumption of a CHO beverage containing glucose and fructose results in improved 100-km cycling performance compared with an isocaloric glucose-only beverage.


2014 ◽  
Vol 24 (5) ◽  
pp. 553-558 ◽  
Author(s):  
Eric C. Haakonssen ◽  
Megan L. Ross ◽  
Louise E. Cato ◽  
Alisa Nana ◽  
Emma J. Knight ◽  
...  

Some athletes avoid dairy in the meal consumed before exercise due to fears about gastrointestinal discomfort. Regular exclusion of dairy foods may unnecessarily reduce intake of high quality proteins and calcium with possible implications for body composition and bone health. This study compared the effects of meals that included (Dairy) or excluded (Control) dairy foods on gastric comfort and subsequent cycling performance. Well-trained female cyclists (n = 32; mean ± SD; 24.3 ± 4.1 y; VO2peak 57.1 ± 4.9 ml/kg/min) completed two trials (randomized cross-over design) in which they consumed a meal (2 g/kg carbohydrate and 54 kJ/kg) 2 hr before a 90-min cycle session (80 min at 60% maximal aerobic power followed by a 10-min time trial; TT). The dairy meal contained 3 servings of dairy foods providing ~1350 mg calcium. Gut comfort and palatability were measured using questionnaires. Performance was measured as maximum mean power during the TT (MMP10min). There was no statistical or clinical evidence of an effect of meal type on MMP10min with a mean difference (Dairy – Control) of 4 W (95% CI [–2, 9]). There was no evidence of an association between pretrial gut comfort and meal type (p = .15) or between gut comfort delta scores and meal type postmeal (p = .31), preexercise (p = .17) or postexercise (p = .80). There was no statistical or clinical evidence of a difference in palatability between meal types. In summary, substantial amounts of dairy foods can be included in meals consumed before strenuous cycling without impairing either gut comfort or performance.


Sign in / Sign up

Export Citation Format

Share Document